Date published: 2026-10-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Flk-1/KDR/VEGFR2 抗体 (F-10): sc-393179

4.3(3)
寫評論提問
说明书
  • Flk-1/KDR/VEGFR2抗体(F-10)是小鼠单克隆IgG2b κ, 在4篇文献中引用,规格为200 µg/ml
  • 特异性抗原位于human物种的Flk-1的C-terminus的氨基酸1292-1321之间
  • 推荐用于 mouse, rat 和 human 来源的VEGFR2 WB, IP, IF, IHC(P) 和 ELISA检测; 也和以下物种反应,包括: 和 equine, canine, bovine and porcine
  • 看 Flk-1/KDR/VEGFR2 (D-8): sc-393163,可查看有标记的 Flk-1/KDR/VEGFR2 抗体,包括AC, HRP, FITC, PE, Alexa Fluor® 488, 594, 647, 680 和 790
  • m-IgG Fc BP-HRP、 2b BP-HRP">m-IgG2b BP-HRP和m-IgGκ BP-HRP是Flk-1/KDR/VEGFR2 Antibody (F-10) 适用于 WB 和 IHC(P) 应用。 的首选辅助检测试剂。这些试剂现与Flk-1/KDR/VEGFR2 Antibody (F-10) 打包提供(请参阅下面的订购信息)。
Gene Editing Promo Banner

快捷链接

関連項目

三种细胞膜受体酪氨酸激酶Flt(也称为VEGF-R1)、Flk-1(也称为VEGF-R2)和Flt-4,可能参与内皮细胞的生长,其特征是细胞外结构域中存在七个免疫球蛋白样序列。这些受体彼此之间具有高度序列相关性,与III类受体(包括CSF-1/Fms、PDGR、SLFR/Kit和Flt-3/Flk-2)具有较低程度的相关性。已显示该受体类的两个成员Flt-1和Flk-1代表血管内皮生长因子(VEGFs)的高亲和力受体。基于与Flt和Flk-1的结构相似性,推测Flt-4可能代表VEGF或VEGF相关配体的第三种受体。

仅限研究使用。不适用于诊断和治疗用途。

Alexa Fluor® 是Molecular Probes Inc., OR., USA的商标

LI-COR®和 Odyssey® 是LI-COR Biosciences的注册商标

Flk-1/KDR/VEGFR2 抗体 (F-10) 参考文献:

  1. VEGFR2易位到细胞核以调节其自身的转录物。  |  Domingues, I., et al. 2011. PLoS One. 6: e25668. PMID: 21980525
  2. VEGFR2在胃癌中以非血管生成依赖的方式促进肿瘤发生和转移。  |  Lian, L., et al. 2019. BMC Cancer. 19: 183. PMID: 30819137
  3. TIPE调节VEGFR2表达并促进结直肠癌的血管生成。  |  Zhong, M., et al. 2020. Int J Biol Sci. 16: 272-283. PMID: 31929755
  4. VEGFR2阻断可改善2型糖尿病肾病实验模型中的肾损伤。  |  Lavoz, C., et al. 2020. J Clin Med. 9: PMID: 31973092
  5. VEGFR2靶向超声分子成像血管生成评估肝同种异体移植纤维化。  |  Qiu, C., et al. 2021. Biomater Sci. 9: 5802-5811. PMID: 34008615
  6. 铜转运蛋白CTR1的半胱氨酸氧化驱动VEGFR2信号传导和血管生成。  |  Das, A., et al. 2022. Nat Cell Biol. 24: 35-50. PMID: 35027734
  7. 血管内皮生长因子受体2在血管生成中的机械调节。  |  Miller, B. and Sewell-Loftin, MK. 2021. Front Cardiovasc Med. 8: 804934. PMID: 35087885
  8. SENP6 介导的血管内皮生长因子受体 2(VEGFR2)去 SUMOylation 能增强其在血管生成过程中的细胞膜转运。  |  He, Q., et al. 2023. Int J Mol Sci. 24: PMID: 36768878
  9. Musashi-2在肺癌中调节VEGFR2和AKT信号。  |  Bychkov, I., et al. 2023. bioRxiv.. PMID: 37034813
  10. Musashi-2在肺癌中调节VEGFR2和AKT信号。  |  Bychkov, I., et al. 2023. Cancers (Basel). 15: PMID: 37173995

订购信息

产品名称产品编号规格价格数量收藏夹

Flk-1/KDR/VEGFR2 抗体 (F-10)

sc-393179
200 µg/ml
CNY2422.00

Flk-1/KDR/VEGFR2 (F-10): m-IgG Fc BP-HRP 套装

sc-538160
200 µg Ab; 10 µg BP
CNY2715.00

Flk-1/KDR/VEGFR2 (F-10): m-IgGκ BP-HRP 套装

sc-535720
200 µg Ab; 40 µg BP
CNY2715.00

Flk-1/KDR/VEGFR2 (F-10): m-IgG2b BP-HRP 套装

sc-549923
200 µg Ab; 10 µg BP
CNY2715.00

Flk-1/KDR/VEGFR2 (F-10) 中和勝肽

sc-393179 P
100 µg/0.5 ml
CNY519.00

do you have a photo of a WB and of IHC from human placenta?

Asked by: DrJohn
Thank you for your question. We do have published Western blot data in human placenta tissue extract on our website. We do not have IHC data in human placenta, but we do have IHC data in human esophagus tissue.
Answered by: Technical Support
Date published: 2019-08-17

What application is the blocking peptide sc-393179 P appropriate for?

Asked by: Trav11
Thank you for your question. The blocking peptide is intended for use as a negative control, by pre-adsorbing the mouse monoclonal antibody against the antigen. For full protocol details, please contact our Technical Services Department or view our online protocol here: https://www.scbt.com/scbt/resources/protocols/peptide-neutralization
Answered by: Technical Support
Date published: 2017-02-24
  • y_2026, m_10, d_24, h_5CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.48
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_2
  • loc_zh_CN, sid_393179, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 95ms
  • QUESTIONS, PRODUCT
Rated 4 out of 5 by JT from Bands detected in WB using human placentaBands detected in WB using human placenta and human skeletal muscle tissue extracts. -SCBT QC
Date published: 2015-05-12
Rated 4 out of 5 by SM from Worked with transfected lysate by WBWorked with transfected lysate by WB -SCBT QC
Date published: 2015-02-01
Rated 5 out of 5 by JM from Produced great immunoperoxidase cytoplasmicProduced great immunoperoxidase cytoplasmic staining in formalin fixed, paraffin-embedded human esophagus tissue. -SCBT QC
Date published: 2015-01-27
  • y_2026, m_10, d_24, h_5
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.48
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_3
  • loc_zh_CN, sid_393179, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 14ms
  • REVIEWS, PRODUCT
Flk-1/KDR/VEGFR2 抗体 (F-10) is rated 4.3 out of 5 by 3.
  • y_2026, m_10, d_24, h_5
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.48
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_3
  • loc_zh_CN, sid_393179, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 92ms
  • REVIEWS, PRODUCT